Founded at the Abramson Cancer Center at the University of Pennsylvania

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies:  clinical perspective and significance

Journal for Immunotherapy of Cancer │ 2018

Michael M. Boviadzis; Madhav V. Dhodapkar; James N. Kochenderfer; Sattva S. Neelapu; Marcela V. Maus; David L. Porter; David G. Maloney; Stephan A. Grupp; Crystal L. Mackall; Carl H. June; Michael R. Bishop